|
Market Closed -
Other stock markets
|
Pre-market 07:56:29 pm | |||
| 616.18 USD | +0.79% |
|
617.53 | +0.22% |
| Market Cap | 62.69B 54.35B 50.1B 46.89B 87.49B 5,977B 89.34B 594B 230B 2,890B 235B 230B 10,056B | P/E ratio 2026 * |
16x | P/E ratio 2027 * | 12.8x |
|---|---|---|---|---|---|
| Enterprise value | 54.78B 47.49B 43.77B 40.98B 76.44B 5,222B 78.06B 519B 201B 2,525B 206B 201B 8,786B | EV / Sales 2026 * |
3.45x | EV / Sales 2027 * | 2.96x |
| Free-Float |
72.33% | Yield 2026 * |
0.64% | Yield 2027 * | 0.72% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +0.79% | ||
| 1 week | +2.58% | ||
| Current month | +0.23% | ||
| 1 month | -13.81% | ||
| 3 months | -18.91% | ||
| 6 months | -12.38% | ||
| Current year | -20.17% |
| 1 week | 599 |  | 640.82 |
| 1 month | 591.52 | | 730.59 |
| Current year | 591.52 | | 821.11 |
| 1 year | 503.25 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 2000-12-31 | |
| Chief Executive Officer | 73 | 1988-01-07 | |
| Director of Finance/CFO | 55 | 2024-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2023-06-08 | |
Michael Brown
BRD | Director/Board Member | 85 | 1991-05-31 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 1991-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Apr. 30 | Sell | Director | -100 | 0.0001% | ||
| Mar. 31 | Sell | Director | 100 | 0.0001% | ||
| Mar. 01 | Sell | Director | 100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.79% | +2.58% | +24.93% | -17.86% | 62.2B | |
| +0.50% | +3.19% | +61.17% | +206.21% | 57.37B | |
| +4.26% | +29.60% | +29.60% | +29.60% | 36.99B | |
| +1.59% | +5.59% | -58.88% | -67.47% | 33.6B | |
| +3.36% | +3.57% | +49.55% | -35.54% | 28.44B | |
| +2.57% | +7.99% | +50.11% | +67.83% | 20.11B | |
| +0.27% | +3.63% | +73.82% | -61.80% | 18.89B | |
| -1.85% | +0.37% | +41.86% | +95.78% | 16.26B | |
| -0.14% | -9.58% | 0.00% | +100.41% | 16.25B | |
| +0.46% | +3.55% | +75.25% | +315.47% | 13.2B | |
| Average | +1.11% | +0.59% | +34.74% | +63.26% | 30.33B | |
| Weighted average by Cap. | +1.32% | +0.75% | +31.85% | +53.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.88B 13.77B 12.69B 11.88B 22.16B 1,514B 22.63B 150B 58.35B 732B 59.63B 58.32B 2,547B | 17.55B 15.22B 14.03B 13.13B 24.5B 1,673B 25.02B 166B 64.49B 809B 65.9B 64.46B 2,816B |
| Net income | 4.09B 3.54B 3.27B 3.06B 5.71B 390B 5.83B 38.72B 15.02B 188B 15.35B 15.01B 656B | 5.13B 4.45B 4.1B 3.84B 7.16B 489B 7.32B 48.62B 18.86B 237B 19.27B 18.85B 823B |
| Net Debt | -7.91B -6.86B -6.32B -5.92B -11.04B -754B -11.28B -74.94B -29.07B -365B -29.71B -29.06B -1,269B | -10.69B -9.26B -8.54B -7.99B -14.91B -1,019B -15.23B -101B -39.26B -493B -40.12B -39.24B -1,714B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-09 | 616.18 $ | +0.79% | 1,057,314 |
| 26-06-08 | 611.34 $ | -3.79% | 1,259,234 |
| 26-06-05 | 635.45 $ | +1.07% | 975,793 |
| 26-06-04 | 628.73 $ | +1.58% | 974,745 |
| 26-06-03 | 618.95 $ | +2.66% | 986,685 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
